Content » Vol 47, Issue 9

Original report

Norwegian constraint-induced therapy multisite trial: Adherence to treatment protocol applied early after stroke

Roland Stock, Gyrd Thrane, Torunn Askim, Gunn Karlsen, Eli Langørgen, Anne Erichsen, Ragna Gjone, Audny Anke
Department of Physical Medicine and Rehabilitation, Trondheim University Hospital, Vådanveien 39, NO-7024 Trondheim, Norway. E-mail: roland.stock@stolav.no, ro-sto@online.no
DOI: 10.2340/16501977-2000

Abstract

Objective: To investigate to what degree patients adhered to a modified constraint-induced movement therapy protocol, and to explore factors associated with the results.
Design: Prospective follow-up of the intervention arm in a randomized controlled trial.
Subjects: Twenty-four patients within 28 days after stroke.
Methods: The protocol specified 180 min of treatment/day for 10 days. Therapy schedules were used to calculate the time spent in shaping, task practice and transfer package, as well as movement quality, perceived exertion and treatment progression.
Results: The participants spent a mean of 91.3% of the intended time for treatment. Time spent practicing tasks was 30 min less than the intended 150 min, whereas slightly more time than intended was spent on the transfer package. Of the time spent in shaping, 33% was spent in pure activity. The remainder was used on feedback, task set-up, and rests. Adherence was positively associated with treatment progression (r = 0.74) and negatively associated with age (r = –0.65). Women were less likely to use the mitt (r = –0.55).
Conclusion: Overall adherence was good; however, time spent in motor activity was only one-third of total treatment time. The parameters in the constraint-induced movement therapy protocol should be individually adjusted early after stroke.

Lay Abstract

Comments

Do you want to comment on this paper? The comments will show up here and if appropriate the comments will also separately be forwarded to the authors. You need to login/create an account to comment on articles. Click here to login/create an account.
Advertisement